CC0 PUBLIC RECORD GRAPH Every score & timeline item links directly to its underlying U.S. FDA record (openFDA, ORA FOIA Reading Room, DECRS & OASIS).
Scoring Formula v2.0 & Legal Guardrails REST API v1
FG
GMPGraphv2.0
Global FDA Facility Graph & Co-Packer Intelligence
21 CFR CLAUSE ENCYCLOPEDIA · 40 ENRICHED CITATION HUBS (1,620 OFFICIAL TEMPLATES)

FDA 21 CFR Citation Encyclopedia & Free SOP Clauses

Every federal cGMP clause cited on FDA Form 483s translated into plain English — with historical citation frequency, inspector red-flag triggers, CAPA remediation playbooks, and copy-paste SOP templates.

🛡️ Audit Your SOPs Against All 1,620 Clauses →
All Programs (40)Bioresearch MonitoringCosmetics (MoCRA)DevicesDietary SupplementsDrugsFoods
21 CFR 211.22(d) Drugs
Rank #1 · 243 Annual FDA Citations
21 CFR 211.22(d): Procedures not in writing, fully followed

Uncontrolled spreadsheets, shared laboratory logins, missing audit trails, backdated entries, or failure to retain batch and distribution records for the statutory window.

Official Inspector Observation Language: "The responsibilities and procedures applicable to the quality control unit are not [in writing] [fully followed]. Specifically, ***..."
Theme: Electronic Record Data Integrity (21 CFR Part 11) & Retention
Open Clause & SOP Template →
21 CFR 211.192 Drugs
Rank #2 · 164 Annual FDA Citations
21 CFR 211.192: Investigations of discrepancies, failures

Failure to perform at least one test to verify the identity of every incoming dietary ingredient or raw component before use, or relying on a supplier's Certificate of Analysis (COA) without first qualifying the supplier.

Official Inspector Observation Language: "There is a failure to thoroughly review [any unexplained discrepancy] [the failure of a batch or any of its components to meet any of its specifications] whether or not the batch has been al..."
Theme: Incoming Ingredient Identity Testing & COA Qualification
Open Clause & SOP Template →
21 CFR 211.100(a) Drugs
Rank #3 · 162 Annual FDA Citations
21 CFR 211.100(a): Absence of Written Procedures

Failure to perform at least one test to verify the identity of every incoming dietary ingredient or raw component before use, or relying on a supplier's Certificate of Analysis (COA) without first qualifying the supplier.

Official Inspector Observation Language: "Your firm failed to establish [adequate] written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality tha..."
Theme: Incoming Ingredient Identity Testing & COA Qualification
Open Clause & SOP Template →
21 CFR 211.160(b) Drugs
Rank #4 · 121 Annual FDA Citations
21 CFR 211.160(b): Scientifically sound laboratory controls

Failure to perform at least one test to verify the identity of every incoming dietary ingredient or raw component before use, or relying on a supplier's Certificate of Analysis (COA) without first qualifying the supplier.

Official Inspector Observation Language: "Laboratory controls do not include the establishment of scientifically sound and appropriate [specifications] [standards] [sampling plans] [test procedures] designed to assure that [componen..."
Theme: Incoming Ingredient Identity Testing & COA Qualification
Open Clause & SOP Template →
21 CFR 211.67(a) Drugs
Rank #5 · 95 Annual FDA Citations
21 CFR 211.67(a): Cleaning / Sanitizing / Maintenance

Failure to perform at least one test to verify the identity of every incoming dietary ingredient or raw component before use, or relying on a supplier's Certificate of Analysis (COA) without first qualifying the supplier.

Official Inspector Observation Language: "Equipment and utensils are not [cleaned] [maintained] [sanitized] at appropriate intervals to prevent [malfunctions] [contamination] that would alter the safety, identity, strength, quality ..."
Theme: Incoming Ingredient Identity Testing & COA Qualification
Open Clause & SOP Template →
21 CFR 211.68(b) Drugs
Rank #6 · 87 Annual FDA Citations
21 CFR 211.68(b): Computer control of master formula records

Operators performing manufacturing or QA tasks without documented GMP/SOP training, or observed gowning/hygiene deviations in production rooms.

Official Inspector Observation Language: "Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized pe..."
Theme: Personnel GMP Training, Gowning & Hygienic Practices
Open Clause & SOP Template →
21 CFR 211.63 Drugs
Rank #7 · 81 Annual FDA Citations
21 CFR 211.63: Equipment Design, Size and Location

Incomplete equipment cleaning/sanitation logs, inadequate allergen or cross-contamination changeover validation, or gaps in facility pest exclusion.

Official Inspector Observation Language: "Equipment used in the manufacture, processing, packing or holding of drug products is not [of appropriate design] [of adequate size] [suitably located] to facilitate operations for its [int..."
Theme: Cleaning Validation, Sanitation Logs & Pest Control
Open Clause & SOP Template →